- Latest available (Revised)
- Original (As adopted by EU)
Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.The immediate packaging of a veterinary medicinal product shall contain the following information and shall, subject to Article 11(4), contain no information other than:
(a)the name of the veterinary medicinal product, followed by its strength and pharmaceutical form;
(b)a statement of the active substances expressed qualitatively and quantitatively per unit or according to the form of administration for a particular volume or weight, using their common names;
(c)the batch number, preceded by the word ‘Lot’;
(d)the name or company name or logo name of the marketing authorisation holder;
(e)the target species;
(f)the expiry date, in the format: ‘mm/yyyy’, preceded by the abbreviation ‘Exp.’;
(g)special storage precautions, if any;
(h)route of administration; and
(i)if applicable, the withdrawal period, even if such period is zero.
2.The information referred to in paragraph 1 of this Article shall appear in easily legible and clearly comprehensible characters, or in abbreviations or pictograms common throughout the Union as listed in accordance with Article 17(2).
3.Notwithstanding paragraph 1, a Member State may decide that, on the immediate packaging of a veterinary medicinal product made available in its territory, an identification code shall be added to the information required under paragraph 1.
1.The outer packaging of a veterinary medicinal product shall contain the following information and shall contain no information other than:
(a)the information referred to in Article 10(1);
(b)the contents by weight, volume or number of immediate packaging units of the veterinary medicinal product;
(c)a warning that the veterinary medicinal product must be kept out of the sight and reach of children;
(d)a warning that the veterinary medicinal product is ‘for animal treatment only’;
(e)without prejudice to Article 14(4), a recommendation to read the package leaflet;
(f)in the case of homeopathic veterinary medicinal products, the statement ‘homeopathic veterinary medicinal product’;
(g)in the case of veterinary medicinal products not subject to a veterinary prescription, the indication or indications;
(h)the marketing authorisation number.
2.A Member State may decide that, on the outer packaging of a veterinary medicinal product made available in its territory, an identification code shall be added to the information required under paragraph 1. Such a code may be used to replace the marketing authorisation number referred to in point (h) of paragraph 1.
3.The information referred to in paragraph 1 of this Article shall appear in easily legible and clearly comprehensible characters, or in abbreviations or pictograms common throughout the Union, as listed in accordance with Article 17(2).
4.Where there is no outer packaging, all the information referred to in paragraphs 1 and 2 shall appear on the immediate packaging.
1.By way of derogation from Article 10, immediate packaging units which are too small to contain in a readable form the information referred to in that Article shall contain the following information and shall contain no information other than:
(a)the name of veterinary medicinal product;
(b)the quantitative particulars of the active substances;
(c)the batch number, preceded by the word ‘Lot’;
(d)the expiry date, in the format: ‘mm/yyyy’, preceded by the abbreviation ‘Exp.’.
2.The immediate packaging units referred to in paragraph 1 of this Article shall have an outer packaging containing information required in Article 11(1), (2) and (3).
By way of derogation from Articles 10(1), 11(1) and 12(1), Member States may, within their territory, and on request of the applicant, allow an applicant to include on the immediate packaging or outer packaging of a veterinary medicinal product additional useful information which is compatible with the summary of the product characteristics and which is not an advertisement for a veterinary medicinal product.
1.The marketing authorisation holder shall make readily available a package leaflet for each veterinary medicinal product. That package leaflet shall contain at least the following information:
(a)the name or company name and permanent address or registered place of business of the marketing authorisation holder and of the manufacturer and, where applicable, of the representative of the marketing authorisation holder;
(b)the name of the veterinary medicinal product, followed by its strength and pharmaceutical form;
(c)qualitative and quantitative composition of the active substance or substances;
(d)the target species, the dosage for each species, the method and route of administration and, if necessary, advice on correct administration;
(e)the indications for use;
(f)the contra-indications and adverse events;
(g)if applicable, the withdrawal period, even if such period is zero;
(h)special storage precautions, if any;
(i)information essential for safety or health protection, including any special precautions relating to use and any other warnings;
(j)information on the collection systems referred to in Article 117 applicable to the veterinary medicinal product concerned;
(k)the marketing authorisation number;
(l)contact details of the marketing authorisation holder or its representative, as appropriate, for the reporting of suspected adverse events;
(m)classification of the veterinary medicinal product as referred to in Article 34.
2.The package leaflet may bear additional information concerning distribution, possession or any necessary precaution in conformity with the marketing authorisation, provided that the information is not promotional. That additional information shall appear in the package leaflet clearly separated from the information referred to in paragraph 1.
3.The package leaflet shall be written and designed to be readable, clear and understandable, in terms that are comprehensible to the general public. Member States may decide that it shall be made available on paper or electronically, or both.
4.By derogation from paragraph 1, the information required in accordance with this Article may, alternatively, be provided on the packaging of the veterinary medicinal product.
The information listed in Articles 10 to 14 shall comply with the summary of the product characteristics as set out in Article 35.
By way of derogation from Article 14(1), the package leaflet of homeopathic veterinary medicinal products registered in accordance with Article 86 shall contain at least the following information:
the scientific name of the stock or stocks followed by the degree of dilution, using the symbols of the European Pharmacopoeia or, in the absence thereof, of the pharmacopoeias used officially in Member States;
name or company name and permanent address or registered place of business of the registration holder and, where appropriate, of the manufacturer;
method of administration and, if necessary, route of administration;
pharmaceutical form;
special storage precautions, if any;
the target species and, where appropriate, dosage for each such species;
a special warning, if necessary, for the homeopathic veterinary medicinal product;
registration number;
withdrawal period, if applicable;
the statement ‘homeopathic veterinary medicinal product’.
1.The Commission shall, when appropriate, by means of implementing acts, establish uniform rules on the identification code referred to in Articles 10(3) and 11(2). Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 145(2).
2.The Commission shall, by means of implementing acts, adopt a list of the abbreviations and pictograms common throughout the Union to be used for the purposes of Articles 10(2) and 11(3). Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 145(2).
3.The Commission shall, by means of implementing acts, provide uniform rules on the size of small immediate packaging units referred to in Article 12. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 145(2).
The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: